A	O
study	B:C2603343
of	O
acute	O
muscle	O
dysfunction	O
with	O
particular	O
reference	O
to	O
dengue	O
myopathy	O
.	O

A	O
study	O
of	O
acute	O
muscle	B:C0026845
dysfunction	O
with	O
particular	O
reference	O
to	O
dengue	O
myopathy	O
.	O

A	O
study	O
of	O
acute	O
muscle	O
dysfunction	O
with	O
particular	O
reference	O
to	O
dengue	B:C0011311
myopathy	O
.	O

A	O
study	O
of	O
acute	O
muscle	O
dysfunction	O
with	O
particular	O
reference	O
to	O
dengue	O
myopathy	B:C0026848
.	O

Acute	B:C1735371
myopathy	I:C1735371
is	O
a	O
common	O
cause	O
of	O
acute	O
motor	I:C0270790
quadriparesis	I:C0270790
which	O
has	O
various	O
etiologies	O
with	O
different	O
courses	O
of	O
illness	O
and	O
prognosis	O
depending	O
on	O
the	O
cause	O
.	O

Acute	O
myopathy	I:C1735371
is	O
a	O
common	O
cause	O
of	O
acute	B:C0270790
motor	I:C0270790
quadriparesis	I:C0270790
which	O
has	O
various	O
etiologies	O
with	O
different	O
courses	O
of	O
illness	O
and	O
prognosis	O
depending	O
on	O
the	O
cause	O
.	O

Acute	O
myopathy	I:C1735371
is	O
a	O
common	O
cause	O
of	O
acute	O
motor	I:C0270790
quadriparesis	I:C0270790
which	O
has	O
various	O
etiologies	O
with	O
different	O
courses	O
of	O
illness	B:C0221423
and	O
prognosis	O
depending	O
on	O
the	O
cause	O
.	O

Acute	O
myopathy	I:C1735371
is	O
a	O
common	O
cause	O
of	O
acute	O
motor	I:C0270790
quadriparesis	I:C0270790
which	O
has	O
various	O
etiologies	O
with	O
different	O
courses	O
of	O
illness	O
and	O
prognosis	B:C0033325
depending	O
on	O
the	O
cause	O
.	O

Understanding	B:C0162340
this	O
diversity	O
helps	O
us	O
in	O
proper	O
approach	O
toward	O
diagnosis	O
,	O
predicting	O
the	O
prognosis	O
,	O
and	O
possible	O
complications	O
and	O
in	O
improving	O
the	O
treatments	O
that	O
are	O
being	O
provided	O
.	O

Understanding	O
this	O
diversity	O
helps	O
us	O
in	O
proper	O
approach	O
toward	O
diagnosis	B:C0011900
,	O
predicting	O
the	O
prognosis	O
,	O
and	O
possible	O
complications	O
and	O
in	O
improving	O
the	O
treatments	O
that	O
are	O
being	O
provided	O
.	O

Understanding	O
this	O
diversity	O
helps	O
us	O
in	O
proper	O
approach	O
toward	O
diagnosis	O
,	O
predicting	O
the	O
prognosis	B:C0033325
,	O
and	O
possible	O
complications	O
and	O
in	O
improving	O
the	O
treatments	O
that	O
are	O
being	O
provided	O
.	O

Understanding	O
this	O
diversity	O
helps	O
us	O
in	O
proper	O
approach	O
toward	O
diagnosis	O
,	O
predicting	O
the	O
prognosis	O
,	O
and	O
possible	O
complications	B:C0009566
and	O
in	O
improving	O
the	O
treatments	O
that	O
are	O
being	O
provided	O
.	O

Understanding	O
this	O
diversity	O
helps	O
us	O
in	O
proper	O
approach	O
toward	O
diagnosis	O
,	O
predicting	O
the	O
prognosis	O
,	O
and	O
possible	O
complications	O
and	O
in	O
improving	O
the	O
treatments	B:C0087111
that	O
are	O
being	O
provided	O
.	O

This	O
study	B:C2603343
was	O
planned	O
to	O
study	O
the	O
clinical	O
,	O
electrophysiological	O
,	O
and	O
etiological	O
profile	O
of	O
patients	O
presenting	O
with	O
acute	O
myopathy	I:C1735371
.	O

This	O
study	O
was	O
planned	O
to	O
study	O
the	O
clinical	O
,	O
electrophysiological	O
,	O
and	O
etiological	O
profile	O
of	O
patients	O
presenting	O
with	O
acute	B:C1735371
myopathy	I:C1735371
.	O

We	O
also	O
studied	O
how	O
dengue	B:C0011311
-	O
related	O
acute	O
myopathy	I:C1735371
differs	O
from	O
other	O
causes	O
and	O
also	O
difference	O
between	O
myopathy	O
due	O
to	O
myositis	O
and	O
hypokalemia	O
in	O
cases	O
of	O
dengue	O
.	O

We	O
also	O
studied	O
how	O
dengue	O
-	O
related	O
acute	B:C1735371
myopathy	I:C1735371
differs	O
from	O
other	O
causes	O
and	O
also	O
difference	O
between	O
myopathy	O
due	O
to	O
myositis	O
and	O
hypokalemia	O
in	O
cases	O
of	O
dengue	O
.	O

We	O
also	O
studied	O
how	O
dengue	O
-	O
related	O
acute	O
myopathy	I:C1735371
differs	O
from	O
other	O
causes	O
and	O
also	O
difference	O
between	O
myopathy	B:C0026848
due	O
to	O
myositis	O
and	O
hypokalemia	O
in	O
cases	O
of	O
dengue	O
.	O

We	O
also	O
studied	O
how	O
dengue	O
-	O
related	O
acute	O
myopathy	I:C1735371
differs	O
from	O
other	O
causes	O
and	O
also	O
difference	O
between	O
myopathy	O
due	O
to	O
myositis	B:C0027121
and	O
hypokalemia	O
in	O
cases	O
of	O
dengue	O
.	O

We	O
also	O
studied	O
how	O
dengue	O
-	O
related	O
acute	O
myopathy	I:C1735371
differs	O
from	O
other	O
causes	O
and	O
also	O
difference	O
between	O
myopathy	O
due	O
to	O
myositis	O
and	O
hypokalemia	B:C0020621
in	O
cases	O
of	O
dengue	O
.	O

We	O
also	O
studied	O
how	O
dengue	O
-	O
related	O
acute	O
myopathy	I:C1735371
differs	O
from	O
other	O
causes	O
and	O
also	O
difference	O
between	O
myopathy	O
due	O
to	O
myositis	O
and	O
hypokalemia	O
in	O
cases	O
of	O
dengue	B:C0011311
.	O

This	O
was	O
a	O
prospective	O
,	O
observational	B:C1518527
study	I:C1518527
involving	O
all	O
clinically	O
suspected	O
cases	O
of	O
acute	O
myopathy	I:C1735371
of	O
not	O
more	O
than	O
4	O
weeks	O
duration	O
with	O
raised	O
serum	O
creatine	O
kinase	I:C0010287
(	O
creatine	O
kinase	I:C0010287
)	O
level	O
.	O

This	O
was	O
a	O
prospective	O
,	O
observational	O
study	I:C1518527
involving	O
all	O
clinically	O
suspected	O
cases	O
of	O
acute	B:C1735371
myopathy	I:C1735371
of	O
not	O
more	O
than	O
4	O
weeks	O
duration	O
with	O
raised	O
serum	O
creatine	O
kinase	I:C0010287
(	O
creatine	O
kinase	I:C0010287
)	O
level	O
.	O

This	O
was	O
a	O
prospective	O
,	O
observational	O
study	I:C1518527
involving	O
all	O
clinically	O
suspected	O
cases	O
of	O
acute	O
myopathy	I:C1735371
of	O
not	O
more	O
than	O
4	O
weeks	O
duration	O
with	O
raised	O
serum	B:C0229671
creatine	O
kinase	I:C0010287
(	O
creatine	O
kinase	I:C0010287
)	O
level	O
.	O

This	O
was	O
a	O
prospective	O
,	O
observational	O
study	I:C1518527
involving	O
all	O
clinically	O
suspected	O
cases	O
of	O
acute	O
myopathy	I:C1735371
of	O
not	O
more	O
than	O
4	O
weeks	O
duration	O
with	O
raised	O
serum	O
creatine	B:C0010287
kinase	I:C0010287
(	O
creatine	O
kinase	I:C0010287
)	O
level	O
.	O

This	O
was	O
a	O
prospective	O
,	O
observational	O
study	I:C1518527
involving	O
all	O
clinically	O
suspected	O
cases	O
of	O
acute	O
myopathy	I:C1735371
of	O
not	O
more	O
than	O
4	O
weeks	O
duration	O
with	O
raised	O
serum	O
creatine	O
kinase	I:C0010287
(	O
creatine	B:C0010287
kinase	I:C0010287
)	O
level	O
.	O

They	O
were	O
subjected	O
to	O
detailed	O
clinical	B:C4084924
evaluation	I:C4084924
along	O
with	O
hematological	O
,	O
biochemical	O
,	O
microbiological	O
,	O
and	O
electrophysiological	O
studies	O
and	O
followed	O
-	I:C1522577
up	I:C1522577
for	O
outcome	O
at	O
1	O
and	O
3	O
months	O
.	O

They	O
were	O
subjected	O
to	O
detailed	O
clinical	O
evaluation	I:C4084924
along	O
with	O
hematological	O
,	O
biochemical	O
,	O
microbiological	B:C0025953
,	O
and	O
electrophysiological	O
studies	O
and	O
followed	O
-	I:C1522577
up	I:C1522577
for	O
outcome	O
at	O
1	O
and	O
3	O
months	O
.	O

They	O
were	O
subjected	O
to	O
detailed	O
clinical	O
evaluation	I:C4084924
along	O
with	O
hematological	O
,	O
biochemical	O
,	O
microbiological	O
,	O
and	O
electrophysiological	O
studies	O
and	O
followed	B:C1522577
-	I:C1522577
up	I:C1522577
for	O
outcome	O
at	O
1	O
and	O
3	O
months	O
.	O

Muscle	B:C0185283
biopsy	I:C0185283
and	O
histopathological	O
examination	O
were	O
done	O
in	O
selected	O
patients	O
after	O
taking	O
informed	O
consent	O
.	O

Muscle	O
biopsy	I:C0185283
and	O
histopathological	O
examination	B:C0582103
were	O
done	O
in	O
selected	O
patients	O
after	O
taking	O
informed	O
consent	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
appropriate	B:C0025663
methods	I:C0025663
using	O
SPSS	O
version	I:C0037585
16.0	I:C0037585
(	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
appropriate	O
methods	I:C0025663
using	O
SPSS	B:C0037585
version	I:C0037585
16.0	I:C0037585
(	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
appropriate	O
methods	I:C0025663
using	O
SPSS	O
version	I:C0037585
16.0	I:C0037585
(	O
Chicago	B:C0008044
,	O
IL	O
,	O
USA	O
)	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
appropriate	O
methods	I:C0025663
using	O
SPSS	O
version	I:C0037585
16.0	I:C0037585
(	O
Chicago	O
,	O
IL	B:C0020898
,	O
USA	O
)	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
appropriate	O
methods	I:C0025663
using	O
SPSS	O
version	I:C0037585
16.0	I:C0037585
(	O
Chicago	O
,	O
IL	O
,	O
USA	B:C0041703
)	O
.	O

We	O
evaluated	O
thirty	O
patients	O
of	O
acute	B:C1735371
myopathy	I:C1735371
with	O
raised	O
creatine	O
kinase	I:C0010287
level	O
.	O

We	O
evaluated	O
thirty	O
patients	O
of	O
acute	O
myopathy	I:C1735371
with	O
raised	O
creatine	B:C0010287
kinase	I:C0010287
level	O
.	O

Seventeen	O
patients	O
had	O
fever	B:C0015967
,	O
11	O
had	O
myalgia	O
,	O
and	O
5	O
had	O
skin	O
lesions	I:C0037284
.	O

Seventeen	O
patients	O
had	O
fever	O
,	O
11	O
had	O
myalgia	B:C0231528
,	O
and	O
5	O
had	O
skin	O
lesions	I:C0037284
.	O

Seventeen	O
patients	O
had	O
fever	O
,	O
11	O
had	O
myalgia	O
,	O
and	O
5	O
had	O
skin	B:C0037284
lesions	I:C0037284
.	O

All	O
presented	O
with	O
symmetric	B:C3714552
weakness	I:C3714552
,	O
17	O
(	O
56.7	O
%	O
)	O
patients	O
having	O
predominantly	O
proximal	O
weakness	I:C0750403
,	O
neck	O
or	O
truncal	O
weakness	I:C0241492
in	O
6	O
(	O
20	O
%	O
)	O
,	O
hyporeflexia	O
in	O
12	O
(	O
40	O
%	O
)	O
,	O
with	O
mean	O
Medical	O
Research	O
Council	O
(	O
MRC	O
)	O
sum	O
score	O
of	O
46.67	O
±	O
6.0	O
.	O

All	O
presented	O
with	O
symmetric	O
weakness	I:C3714552
,	O
17	O
(	O
56.7	O
%	O
)	O
patients	O
having	O
predominantly	O
proximal	B:C0750403
weakness	I:C0750403
,	O
neck	O
or	O
truncal	O
weakness	I:C0241492
in	O
6	O
(	O
20	O
%	O
)	O
,	O
hyporeflexia	O
in	O
12	O
(	O
40	O
%	O
)	O
,	O
with	O
mean	O
Medical	O
Research	O
Council	O
(	O
MRC	O
)	O
sum	O
score	O
of	O
46.67	O
±	O
6.0	O
.	O

All	O
presented	O
with	O
symmetric	O
weakness	I:C3714552
,	O
17	O
(	O
56.7	O
%	O
)	O
patients	O
having	O
predominantly	O
proximal	O
weakness	I:C0750403
,	O
neck	B:C0027530
or	O
truncal	O
weakness	I:C0241492
in	O
6	O
(	O
20	O
%	O
)	O
,	O
hyporeflexia	O
in	O
12	O
(	O
40	O
%	O
)	O
,	O
with	O
mean	O
Medical	O
Research	O
Council	O
(	O
MRC	O
)	O
sum	O
score	O
of	O
46.67	O
±	O
6.0	O
.	O

All	O
presented	O
with	O
symmetric	O
weakness	I:C3714552
,	O
17	O
(	O
56.7	O
%	O
)	O
patients	O
having	O
predominantly	O
proximal	O
weakness	I:C0750403
,	O
neck	O
or	O
truncal	B:C0241492
weakness	I:C0241492
in	O
6	O
(	O
20	O
%	O
)	O
,	O
hyporeflexia	O
in	O
12	O
(	O
40	O
%	O
)	O
,	O
with	O
mean	O
Medical	O
Research	O
Council	O
(	O
MRC	O
)	O
sum	O
score	O
of	O
46.67	O
±	O
6.0	O
.	O

All	O
presented	O
with	O
symmetric	O
weakness	I:C3714552
,	O
17	O
(	O
56.7	O
%	O
)	O
patients	O
having	O
predominantly	O
proximal	O
weakness	I:C0750403
,	O
neck	O
or	O
truncal	O
weakness	I:C0241492
in	O
6	O
(	O
20	O
%	O
)	O
,	O
hyporeflexia	B:C0151888
in	O
12	O
(	O
40	O
%	O
)	O
,	O
with	O
mean	O
Medical	O
Research	O
Council	O
(	O
MRC	O
)	O
sum	O
score	O
of	O
46.67	O
±	O
6.0	O
.	O

Eight	O
(	O
mean	B:C0282574
modified	I:C0282574
Barthel	I:C0282574
index	I:C0282574
[	O
modified	O
Barthel	I:C0282574
index	I:C0282574
]	O
at	O
presentation	O
-	O
15	O
±	O
3.7	O
)	O
patients	O
had	O
poor	O
functional	O
status	I:C0598463
according	O
to	O
modified	O
Barthel	I:C0282574
index	I:C0282574
and	O
15	O
according	O
to	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
(	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
)	O
(	O
mean	O
MRS	O
score	I:C3828944
-	O
2.5	O
±	O
1.2	O
)	O
.	O

Eight	O
(	O
mean	O
modified	I:C0282574
Barthel	I:C0282574
index	I:C0282574
[	O
modified	B:C0282574
Barthel	I:C0282574
index	I:C0282574
]	O
at	O
presentation	O
-	O
15	O
±	O
3.7	O
)	O
patients	O
had	O
poor	O
functional	O
status	I:C0598463
according	O
to	O
modified	O
Barthel	I:C0282574
index	I:C0282574
and	O
15	O
according	O
to	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
(	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
)	O
(	O
mean	O
MRS	O
score	I:C3828944
-	O
2.5	O
±	O
1.2	O
)	O
.	O

Eight	O
(	O
mean	O
modified	I:C0282574
Barthel	I:C0282574
index	I:C0282574
[	O
modified	O
Barthel	I:C0282574
index	I:C0282574
]	O
at	O
presentation	O
-	O
15	O
±	O
3.7	O
)	O
patients	O
had	O
poor	O
functional	B:C0598463
status	I:C0598463
according	O
to	O
modified	O
Barthel	I:C0282574
index	I:C0282574
and	O
15	O
according	O
to	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
(	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
)	O
(	O
mean	O
MRS	O
score	I:C3828944
-	O
2.5	O
±	O
1.2	O
)	O
.	O

Eight	O
(	O
mean	O
modified	I:C0282574
Barthel	I:C0282574
index	I:C0282574
[	O
modified	O
Barthel	I:C0282574
index	I:C0282574
]	O
at	O
presentation	O
-	O
15	O
±	O
3.7	O
)	O
patients	O
had	O
poor	O
functional	O
status	I:C0598463
according	O
to	O
modified	B:C0282574
Barthel	I:C0282574
index	I:C0282574
and	O
15	O
according	O
to	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
(	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
)	O
(	O
mean	O
MRS	O
score	I:C3828944
-	O
2.5	O
±	O
1.2	O
)	O
.	O

Eight	O
(	O
mean	O
modified	I:C0282574
Barthel	I:C0282574
index	I:C0282574
[	O
modified	O
Barthel	I:C0282574
index	I:C0282574
]	O
at	O
presentation	O
-	O
15	O
±	O
3.7	O
)	O
patients	O
had	O
poor	O
functional	O
status	I:C0598463
according	O
to	O
modified	O
Barthel	I:C0282574
index	I:C0282574
and	O
15	O
according	O
to	O
modified	B:C2984908
Rankin	I:C2984908
scale	I:C2984908
(	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
)	O
(	O
mean	O
MRS	O
score	I:C3828944
-	O
2.5	O
±	O
1.2	O
)	O
.	O

Eight	O
(	O
mean	O
modified	I:C0282574
Barthel	I:C0282574
index	I:C0282574
[	O
modified	O
Barthel	I:C0282574
index	I:C0282574
]	O
at	O
presentation	O
-	O
15	O
±	O
3.7	O
)	O
patients	O
had	O
poor	O
functional	O
status	I:C0598463
according	O
to	O
modified	O
Barthel	I:C0282574
index	I:C0282574
and	O
15	O
according	O
to	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
(	O
modified	B:C2984908
Rankin	I:C2984908
scale	I:C2984908
)	O
(	O
mean	O
MRS	O
score	I:C3828944
-	O
2.5	O
±	O
1.2	O
)	O
.	O

Eight	O
(	O
mean	O
modified	I:C0282574
Barthel	I:C0282574
index	I:C0282574
[	O
modified	O
Barthel	I:C0282574
index	I:C0282574
]	O
at	O
presentation	O
-	O
15	O
±	O
3.7	O
)	O
patients	O
had	O
poor	O
functional	O
status	I:C0598463
according	O
to	O
modified	O
Barthel	I:C0282574
index	I:C0282574
and	O
15	O
according	O
to	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
(	O
modified	O
Rankin	I:C2984908
scale	I:C2984908
)	O
(	O
mean	O
MRS	B:C3828944
score	I:C3828944
-	O
2.5	O
±	O
1.2	O
)	O
.	O

Etiology	O
was	O
dengue	B:C0011315
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	O
,	O
thyrotoxicosis	O
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	B:C0042769
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	O
,	O
thyrotoxicosis	O
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	B:C0020621
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	O
,	O
thyrotoxicosis	O
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	B:C0011311
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	O
,	O
thyrotoxicosis	O
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	B:C1704275
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	O
,	O
thyrotoxicosis	O
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	B:C0011633
,	O
polymyositis	O
,	O
thyrotoxicosis	O
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	B:C0085655
,	O
thyrotoxicosis	O
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	O
,	O
thyrotoxicosis	B:C0040156
,	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Etiology	O
was	O
dengue	O
viral	O
infection	I:C0042769
in	O
14	O
patients	O
;	O
hypokalemia	O
due	O
to	O
various	O
causes	O
other	O
than	O
dengue	O
in	O
8	O
;	O
pyomyositis	O
in	O
3	O
;	O
dermatomyositis	O
,	O
polymyositis	O
,	O
thyrotoxicosis	O
,	O
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
,	O
and	O
unknown	O
etiology	O
in	O
one	O
each	O
.	O

Only	O
eight	O
patients	O
had	O
abnormal	B:C0205161
electrophysiology	O
and	O
seven	O
among	O
nine	O
biopsies	O
done	O
were	O
abnormal	O
.	O

Only	O
eight	O
patients	O
had	O
abnormal	O
electrophysiology	B:C1446476
and	O
seven	O
among	O
nine	O
biopsies	O
done	O
were	O
abnormal	O
.	O

Only	O
eight	O
patients	O
had	O
abnormal	O
electrophysiology	O
and	O
seven	O
among	O
nine	O
biopsies	B:C0005558
done	O
were	O
abnormal	O
.	O

Only	O
eight	O
patients	O
had	O
abnormal	O
electrophysiology	O
and	O
seven	O
among	O
nine	O
biopsies	O
done	O
were	O
abnormal	B:C0205161
.	O

At	O
1	O
month	O
,	O
24	O
(	O
80.0	O
%	O
)	O
and	O
23	O
(	O
76.7	O
%	O
)	O
patients	O
had	O
achieved	O
normal	O
modified	B:C0282574
Barthel	I:C0282574
index	I:C0282574
and	O
MRS	O
scores	I:C3828944
with	O
28	O
(	O
93.3	O
)	O
and	O
27	O
(	O
90	O
%	O
)	O
patients	O
,	O
respectively	O
,	O
at	O
3	O
months	O
.	O

At	O
1	O
month	O
,	O
24	O
(	O
80.0	O
%	O
)	O
and	O
23	O
(	O
76.7	O
%	O
)	O
patients	O
had	O
achieved	O
normal	O
modified	O
Barthel	I:C0282574
index	I:C0282574
and	O
MRS	B:C3828944
scores	I:C3828944
with	O
28	O
(	O
93.3	O
)	O
and	O
27	O
(	O
90	O
%	O
)	O
patients	O
,	O
respectively	O
,	O
at	O
3	O
months	O
.	O

Dengue	B:C0011311
with	O
hypokalemia	O
had	O
less	O
myalgia	O
,	O
more	O
of	O
hyporeflexia	O
,	O
and	O
lower	O
serum	O
creatine	O
kinase	I:C0010287
compared	O
to	O
those	O
without	O
hypokalemia	O
.	O

Dengue	O
with	O
hypokalemia	B:C0020621
had	O
less	O
myalgia	O
,	O
more	O
of	O
hyporeflexia	O
,	O
and	O
lower	O
serum	O
creatine	O
kinase	I:C0010287
compared	O
to	O
those	O
without	O
hypokalemia	O
.	O

Dengue	O
with	O
hypokalemia	O
had	O
less	O
myalgia	B:C0231528
,	O
more	O
of	O
hyporeflexia	O
,	O
and	O
lower	O
serum	O
creatine	O
kinase	I:C0010287
compared	O
to	O
those	O
without	O
hypokalemia	O
.	O

Dengue	O
with	O
hypokalemia	O
had	O
less	O
myalgia	O
,	O
more	O
of	O
hyporeflexia	B:C0151888
,	O
and	O
lower	O
serum	O
creatine	O
kinase	I:C0010287
compared	O
to	O
those	O
without	O
hypokalemia	O
.	O

Dengue	O
with	O
hypokalemia	O
had	O
less	O
myalgia	O
,	O
more	O
of	O
hyporeflexia	O
,	O
and	O
lower	O
serum	B:C0229671
creatine	O
kinase	I:C0010287
compared	O
to	O
those	O
without	O
hypokalemia	O
.	O

Dengue	O
with	O
hypokalemia	O
had	O
less	O
myalgia	O
,	O
more	O
of	O
hyporeflexia	O
,	O
and	O
lower	O
serum	O
creatine	B:C0010287
kinase	I:C0010287
compared	O
to	O
those	O
without	O
hypokalemia	O
.	O

Dengue	O
with	O
hypokalemia	O
had	O
less	O
myalgia	O
,	O
more	O
of	O
hyporeflexia	O
,	O
and	O
lower	O
serum	O
creatine	O
kinase	I:C0010287
compared	O
to	O
those	O
without	O
hypokalemia	B:C0020621
.	O

Dengue	B:C0011311
infection	I:C0011311
and	O
hypokalemia	O
due	O
to	O
various	O
causes	O
are	O
the	O
most	O
common	O
causes	O
of	O
acute	O
myopathy	I:C1735371
and	O
are	O
associated	O
with	O
rapid	O
and	O
complete	O
recovery	I:C2826210
within	O
1	O
month	O
.	O

Dengue	O
infection	I:C0011311
and	O
hypokalemia	B:C0020621
due	O
to	O
various	O
causes	O
are	O
the	O
most	O
common	O
causes	O
of	O
acute	O
myopathy	I:C1735371
and	O
are	O
associated	O
with	O
rapid	O
and	O
complete	O
recovery	I:C2826210
within	O
1	O
month	O
.	O

Dengue	O
infection	I:C0011311
and	O
hypokalemia	O
due	O
to	O
various	O
causes	O
are	O
the	O
most	O
common	O
causes	O
of	O
acute	B:C1735371
myopathy	I:C1735371
and	O
are	O
associated	O
with	O
rapid	O
and	O
complete	O
recovery	I:C2826210
within	O
1	O
month	O
.	O

Dengue	O
infection	I:C0011311
and	O
hypokalemia	O
due	O
to	O
various	O
causes	O
are	O
the	O
most	O
common	O
causes	O
of	O
acute	O
myopathy	I:C1735371
and	O
are	O
associated	O
with	O
rapid	O
and	O
complete	B:C2826210
recovery	I:C2826210
within	O
1	O
month	O
.	O

Shorter	O
duration	O
of	O
illness	B:C0221423
,	O
higher	O
MRC	O
sum	O
score	O
,	O
better	O
disability	O
status	O
at	O
presentation	O
,	O
lower	O
serum	O
creatine	O
kinase	I:C0010287
correlate	O
with	O
better	O
outcome	O
.	O

Shorter	O
duration	O
of	O
illness	O
,	O
higher	O
MRC	O
sum	O
score	O
,	O
better	O
disability	O
status	O
at	O
presentation	O
,	O
lower	O
serum	B:C0229671
creatine	O
kinase	I:C0010287
correlate	O
with	O
better	O
outcome	O
.	O

Shorter	O
duration	O
of	O
illness	O
,	O
higher	O
MRC	O
sum	O
score	O
,	O
better	O
disability	O
status	O
at	O
presentation	O
,	O
lower	O
serum	O
creatine	B:C0010287
kinase	I:C0010287
correlate	O
with	O
better	O
outcome	O
.	O

Biopsy	B:C0005558
was	O
decisive	O
in	O
<	O
20	O
%	O
cases	O
;	O
hence	O
,	O
it	O
is	O
not	O
primary	O
investigation	O
in	O
acute	O
myopathy	I:C1735371
.	O

Biopsy	O
was	O
decisive	O
in	O
<	O
20	O
%	O
cases	O
;	O
hence	O
,	O
it	O
is	O
not	O
primary	O
investigation	B:C0220825
in	O
acute	O
myopathy	I:C1735371
.	O

Biopsy	O
was	O
decisive	O
in	O
<	O
20	O
%	O
cases	O
;	O
hence	O
,	O
it	O
is	O
not	O
primary	O
investigation	O
in	O
acute	B:C1735371
myopathy	I:C1735371
.	O

